Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel (KATP channel) in pancreatic beta cells is an octameric complex of four Kir6.2 pore-forming subunits (encoded by KCNJ11) and four sulfonylurea receptor 1 (SUR1) regulatory subunits (encoded by ABCC8), functioning as a metabolic sensor that links glucose levels to insulin secretion. Under low glucose, high ADP/ATP ratios keep channels open, maintaining hyperpolarized membrane potential; elevated glucose boosts ATP, closing channels, depolarizing the cell, opening voltage-gated calcium channels, and triggering calcium-dependent insulin exocytosis. Mutations in KCNJ11 or ABCC8 cause diseases like neonatal diabetes (reduced function) or congenital hyperinsulinism (gain-of-function), highlighting its role in glucose homeostasis. Therapeutically, sulfonylureas like glibenclamide bind SUR1 to inhibit channels and boost insulin for type 2 diabetes treatment, while diazoxide opens channels to suppress insulin in hyperinsulinism. Structural studies reveal nucleotide binding at Kir6.2 interfaces and SUR1 conformational changes coupling metabolism to gating, with challenges including hypoglycemia risk and tissue-specific isoforms.
Closure by sulfonylureas to depolarize beta cells and promote insulin release; opening by diazoxide to hyperpolarize and inhibit insulin secretion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-sensitive potassium channel (KATP channel), pancreatic beta cell (KATP channel).